Doyle D J, Chesterman C N, Cade J F, McGready J R, Rennie G C, Morgan F J
Blood. 1980 Jan;55(1):82-4.
Relationships between 51Cr platelet survival and plasma concentrations of beta-thromboglobulin (betaTG) and platelet factor 4 (PF4) were analyzed in 91 studies of patients with coronary artery disease. betaTG was significantly correlated with platelet life-span, turnover, and the number of hits in the multiple hit model. PF4 was significantly correlated with life-span and turnover. The most significant relationship involving platelet-specific protein concentrations and life-span estimates was between betaTG and life-span estimated using the multiple hit model (r = -0.39, p less than 0.001). There was a high correlation between betaTG and PF4 (r = 0.62, p less than 0.001), and no improvement could be obtained by combining the measurements of the two proteins in any regression with life-span or turnover. The results indicate that the patients with the shortest platelet survival time in this group tended to have the highest plasma concentration of betaTG and PF4 and thus probably increased in vivo release of betaTG and PF4. They strengthen the claim that these platelet-specific proteins may be indicators of platelet involvement in disease.
在91项针对冠心病患者的研究中,分析了51铬标记血小板存活时间与血浆β-血小板球蛋白(βTG)和血小板因子4(PF4)浓度之间的关系。βTG与血小板寿命、周转率以及多次打击模型中的打击次数显著相关。PF4与寿命和周转率显著相关。涉及血小板特异性蛋白浓度和寿命估计的最显著关系存在于βTG与使用多次打击模型估计的寿命之间(r = -0.39,p < 0.001)。βTG与PF4之间存在高度相关性(r = 0.62,p < 0.001),在任何与寿命或周转率的回归分析中,将两种蛋白的测量值结合起来都无法提高相关性。结果表明,该组中血小板存活时间最短的患者往往血浆βTG和PF4浓度最高,因此体内βTG和PF4的释放可能增加。这些结果强化了这样一种观点,即这些血小板特异性蛋白可能是血小板参与疾病的指标。